Related Experiment Video
Updated: Jul 15, 2025

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Trace Element Concentrations in Autopsied Heart Tissues from Patients with Secondary Cardiomyopathy
Ana Ćirović1, Aleksandra Buha Đorđević2,3, Aleksandar Ćirović4
1Faculty of Medicine, Institute of Anatomy, University of Belgrade, Dr Subotica 4/2, 11000, Belgrade, Serbia.
Insights
Cardiomyopathy patients show higher levels of lead, nickel, manganese, and copper in heart tissue. Essential zinc levels were significantly lower in individuals with cardiomyopathy (CMP).
Area of Science:
- Cardiology
- Toxicology
- Environmental Health
Background:
- Cardiomyopathies (CMP) are a major cause of heart failure and transplantation, with poor long-term outcomes.
- Heavy metals are known cardiotoxins, with elevated levels observed in blood and urine of heart disease patients.
- Direct myocardial metal analysis in CMP has been lacking, particularly for essential metals like zinc (Zn).
Purpose of the Study:
- To investigate and quantify metal concentrations in the left ventricle myocardium of individuals with CMP.
- To compare metal profiles in CMP patients versus non-heart disease controls.
Main Methods:
- Post-mortem left ventricle myocardial samples were collected from 52 individuals.
- 19 samples were from diagnosed CMP patients (mean age 72 ± 10 years).
- 33 samples were from individuals without heart disease (mean age 67 ± 15 years).
- Metal concentrations (including lead, nickel, manganese, copper, and zinc) were analyzed.
Main Results:
- CMP patients exhibited significantly higher concentrations of lead, nickel, manganese, and copper compared to controls (p ≤ 0.011).
- Zinc levels were significantly lower in the myocardium of CMP subjects (p = 0.017).
- These findings suggest an altered metal burden in the heart tissue of individuals with CMP.
Conclusions:
- Increased myocardial concentrations of lead, nickel, manganese, and copper are associated with cardiomyopathy.
- Reduced zinc levels in the heart may also play a role in CMP pathogenesis.
- These results highlight the potential cardiotoxic effects of specific heavy metals and the importance of essential minerals in heart health.
Abstract:
Cardiomyopathies (CMP) represent a significant health problem as they have a poor long-term prognosis and often require transplantation. Heavy metals are known to have cardiotoxic effects and some of them, such as cadmium (Cd), are found to be elevated in the urine and blood of individuals with heart diseases; nevertheless, direct measurement of metals (e.g. zinc (Zn) which is necessary for normal heart function), in the myocardium of individuals with CMP has not been performed. Here, we aimed to analyze the levels of a group of metals in the myocardium of the left ventricle in individuals with CMP. At the Institute of Pathology, we collected 52 samples of left ventricle post-mortem, out of which 19 subjects had been diagnosed with CMP (mean age: 72 y ± 10), and 33 subjects had not suffered from any heart disease (mean age: 67 y ± 15). We found out that individuals with CMP had a significantly higher concentrations of lead, nickel, manganese and copper than non-CMP subjects (p = 0.002, p < 0.001, p = 0.011, and p = 0.002). Interestingly, zinc was significantly lower in CMP subjects than in n-CMP individuals (p = 0.017). Our results indicated the involvement of an increased lead, nickel, copper and manganese heart load in individuals with CMP coupled with lower concentrations of zinc.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

